Telehealth Services for Mental Health Care: A Secret Shopper Study

By HEOR Staff Writer

February 22, 2024

Introduction:

There have been major shifts in healthcare delivery due to the recent pandemic, with telehealth being one area that has seen the most impact. In the United States, the use of telehealth services for mental health care has seen a remarkable increase, fuelled by changes in federal and state policies related to financial reimbursement of these services.

The Rise of Telehealth in Mental Health Care:

Particularly in the midst of the epidemic, telehealth has emerged as an indispensable instrument for the delivery of mental health treatments. According to studies, the overall volume of services for mental health issues has remained consistent, despite constraints on in-person care. This can be partly due to the rise in the number of telehealth appointments. On the other hand, the availability of these telehealth services and the makeup of these services are still substantially unexplored.

The Secret Shopper Approach:

A ‘Secret Shopper’ strategy was utilised in a recent study in order to gain an understanding of the present landscape of telehealth services for mental health care professionals. In this approach, researchers make contact with establishments while posing as potential customers in order to inquire about the availability of services. By taking this method, a clear and up-to-date image of the layout of services across the United States is provided.

Findings and Discussions:

The survey revealed that approximately one in five facilities did not respond despite multiple attempts. Among those successfully contacted, most were accepting new clients and offering telehealth services. However, the availability of telehealth services varied across states, and there was heterogeneity in the types of clinical services offered via telehealth.

Figure 1. State-Specific Median Wait Times to Next Available Telehealth Appointment
at Surveyed Mental Health Treatment Facilities

The survey also found that the median wait time for a telehealth appointment was over two weeks, with significant geographic variation. Interestingly, private facilities were nearly twice as likely to offer telehealth services compared with public facilities.

Implications and Future Directions:

These findings underscore potential heterogeneity in the availability of treatment from specialty practitioners in the US. More work is needed to investigate the possible reasons for these differences. Policymakers should consider broadening policies allowing facilities to offer telehealth across state lines to improve telehealth wait times.

Figure 2. State-Specific Proportions of Surveyed Mental Health Treatment Facilities
With Reported Telehealth Services

Conclusion:

The COVID-19 pandemic has undeniably accelerated the shift towards telehealth in mental health care. However, prospective clients may face several hurdles in finding a facility that offers comprehensive telehealth services. Therefore, it is paramount to continue exploring ways to optimise the availability and accessibility of these services.

Reference url

Recent Posts

Social Media Policy Action: Protecting Youth from Cognitive Risks

By João L. Carapinha

October 16, 2025

A recent editorial published in JAMA emphasizes the urgent need for social media policy action due to the developmental impacts of social media on youth. The article discusses a pivotal study by Nagata et al., which examined a large cohort of adolescents. This study revealed that increas...
Colorectal Cancer Markers: Discovering Region-Specific Drivers for Precision Oncology

By HEOR Staff Writer

October 15, 2025

Colorectal cancer markers like NOX1 and NPY1R are changing the way experts diagnose and manage colon cancer. But how do these region-specific markers impact colorectal cancer detection, prognosis, and personalized therapies? Recent breakthroughs show that understanding where a tumor begins—with t...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Triple-Negative Breast Ca...

By João L. Carapinha

October 13, 2025

Datroway TNBC therapy (datopotamab deruxtecan) has demonstrated statistically significant and clinically meaningful improvements in overall survival (OS) and progression-free survival (PFS) as a first-line treatment compared to chemotherapy in patients with metastatic triple-negative breast cance...